Two new US patents to Australia Life Science companies

248 Life Science patents (classification A61K) were issued by the US Patent and Trademark Office on Tuesday 23 August 2016 (click here). Two of them went to Australian licensees.

US Patent 9,421,205 has been granted to the Cancer Therapeutics CRC for FAK inhibitors.

US Patent 9,422,522 has gone to Regenertech Pty Ltd, an Australian company owned by the New Zealand physician Dr Vishal Bhasin. This latter patent covers a method of differentiating fibroblast cells into adipocytes, a technique potentially useful in organ regeneration. Check out our list of recent US patent issuance by clicking here.